Augustina Isioma Ikusemoro: Why Plasma and RBC Transfusions Follow Different Compatibility Rules
Augustina Isioma Ikusemoro, Hematology and Transfusion Medicine Specialist at Sharjah Blood Transfusion and Research Center, shared a post on LinkedIn:
“The wrong blood product can turn a life-saving transfusion into a life-threatening mistake.
ABO compatibility is not just laboratory science – it is patient safety.
One of the most misunderstood areas in transfusion medicine is this:
RBC compatibility and plasma compatibility are not the same.
For Red Blood Cells (RBCs):
We avoid giving antigens the patient does not have.
- Group O – universal RBC donor
- Group AB – universal RBC recipient
But for Plasma (FFP):
The rule is reversed.
- Group AB plasma – universal plasma donor
- Group O patients – can receive plasma from all groups
And what happens in emergencies when AB plasma is unavailable for an AB patient?
Clinical judgment matters.
Low-titer Group A plasma may be the preferred alternative.
Low-titer Group O plasma may be used as a last resort.
Group B plasma should generally be avoided.
The key lesson?
Knowing compatibility saves lives.
Because in transfusion medicine:
Right patient. Right product. Right time.
Not all blood products follow the same compatibility rules – and understanding the difference can prevent avoidable transfusion reactions.
Signature of Blood Doki. Educate. Empower. Elevate. Better blood. Better care. Better outcomes.”

Other posts featuring Augustina Isioma Ikusemoro on Hemostasis Today.
-
Nov 18, 2026, 01:45Shikha Jha: My Takeaways from the 4th GANSID International Congress
-
Nov 18, 2026, 01:34Zeeshan Ahmed Khattak: Treatment of Fever and Neutropenia in Hematology/Oncology and Hematopoietic Cell Transplant Patients
-
Nov 17, 2026, 23:45Cajetan Reichardt: LAAO vs. OAC in AF – Balancing Nonprocedural Bleeding and Ischemic Stroke Risk
-
Nov 17, 2026, 23:42Brian Tegtmeyer: Expanding Pre-Hospital Administration of Low-Titer O Positive Whole Blood
-
Nov 17, 2026, 23:41Mansi Kala: Advancing Hematology – From Evidence to Clinical Excellence
-
Nov 17, 2026, 23:40Nathan Connell: Registered for the WFH Comprehensive Care Summit 2027 in Prague
-
Nov 17, 2026, 23:38Yaariv Khaykin: Does Reducing AF Burden After Ablation Change the Need for Anticoagulation?
-
Nov 17, 2026, 23:38Amos Gitonga Mbaabu: Strengthening Care and Advocacy for Haemophilia and SCD across Southern Africa
-
Nov 17, 2026, 23:35Muhammad Sameed Altaf: A Decade of Working Together for Thalassemia Awareness and Patient Support